Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy | Zendy

Reshmie Ramautarsing | Zendy; Jasper van der Lugt | Zendy; Meena Gorowara | Zendy; Stephen J. Kerr | Zendy; David M. Burger | Zendy; Kiat Ruxrungtham | Zendy; Praphan Phanuphak | Zendy; Surasith Chaithongwongwatthana | Zendy; Anchalee Avihingsa | Zendy; Nittaya Phanuphak | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy

Author(s) -

Reshmie Ramautarsing,

Jasper van der Lugt,

Meena Gorowara,

Stephen J. Kerr,

David M. Burger,

Kiat Ruxrungtham,

Praphan Phanuphak,

Surasith Chaithongwongwatthana,

Anchalee Avihingsa,

Nittaya Phanuphak

Publication year - 2011

Publication title -

aids

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.195

H-Index - 216

eISSN - 1473-5571

pISSN - 0269-9370

DOI - 10.1097/qad.0b013e328347f7e9

Subject(s) - lopinavir , lopinavir/ritonavir , cmin , medicine , ritonavir , cmax , pharmacokinetics , interquartile range , pregnancy , confidence interval , discontinuation , obstetrics , gestational age , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , immunology , biology , genetics

To investigate whether Thai HIV-1-infected pregnant women require a dose increase of lopinavir/ritonavir (LPV/r) and to assess the safety and efficacy of the generic tablets during pregnancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research